Your browser doesn't support javascript.
loading
Successful treatment of central nervous system involved Erdheim-Chester disease by intermediate-dose cytarabine as first-line therapy.
Wang, Ji-Nuo; Qiu, Yu; Niu, Na; Zhang, Yan; Li, Jian; Zhou, Dao-Bin; Cao, Xin-Xin.
Afiliação
  • Wang JN; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Qiu Y; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Niu N; Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Zhang Y; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Li J; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Zhou DB; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Cao XX; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Acta Oncol ; 59(3): 302-305, 2020 Mar.
Article em En | MEDLINE | ID: mdl-31559889

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças do Sistema Nervoso Central / Citarabina / Doença de Erdheim-Chester / Imunossupressores Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans Idioma: En Revista: Acta Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças do Sistema Nervoso Central / Citarabina / Doença de Erdheim-Chester / Imunossupressores Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans Idioma: En Revista: Acta Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China
...